JDD in the Media

December Article Citations

By December 3, 2019No Comments
“Men may have different reasons for visiting a cosmetic surgeon’s office, but one fairly universal concern they share is wanting to maintain (or enhance) their masculinity.” 

The number of Nonsurgical aesthetic procedures performed for male patients is growing is growing rapidly. However, there is limited data on treatment principles and goals for the male aesthetic patient.

In an article from Dermatology Times,  Katie Hobbins cites findings from research published in the January 2018 issue of the Journal of Drugs in Dermatology ( The Male Aesthetic Patient: Facial Anatomy, Concepts of Attractiveness, and Treatment Patterns“) that reports a “lack of information available on male aesthetic treatments and goals contributes to the disproportionately small national percentage of men seeking the advice of a cosmetic physician when compared to women. “

Expert advisors met to discuss anatomical differences in male versus female facial anatomy related to aging, facial treatment preferences in aesthetically oriented men, and current dosing data for facial injectable treatments in male versus female patients.

Read Article Now

You May Also Like

Atopic DermatitisDermatology RoundupJDD HighlightsJDD in the MediaThe Latest
October 17, 2024

Dermatology Roundup: Semaglutide for HS, Acne Laser Receives FDA Clearance

By Allison Sit Semaglutide – a glucagon-like peptide (GLP)-1RA – improved outcomes for obese patients with hidradenitis suppurativa (HS), according to a study presented at EADV Congress 2024. The study…
Atopic DermatitisDermatology RoundupJDD HighlightsJDD in the MediaThe Latest
September 24, 2024

Dermatology Roundup: National Eczema Association Aims to Define “Flare”

By Allison Sit A National Eczema Association (NEA) study published in JAMA Dermatology identified patient-reported attributes associated with a “flare” of atopic dermatitis. The study sought to develop a clearer…
AcneAtopic DermatitisFeatured ArticlesJDD HighlightsJDD in the MediaPsoriasisSkin of ColorThe Latest
September 19, 2024

JDD in the News: Benefits of Long-Term Ixekizumab in Psoriasis; Secukinumab in Psoriasis Patients with Skin of Color

by Allison Sit Healio wrote about two JDD studies on psoriasis treatments including one on the benefits of long-term ixekizumab. The study, “Benefits Over Five Years of Ixekizumab Treatment in…